IDL Biotech AB (XSAT:IDL) EV-to-Revenue : 9.09 (As of May. 25, 2024)

IDL Biotech AB EV-to-Revenue Chart

IDL Biotech AB Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
EV-to-Revenue		Get a 7-Day Free Trial					2.41	2.30	5.44	9.50	4.30

IDL Biotech AB Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
EV-to-Revenue	Get a 7-Day Free Trial															7.38	4.56	4.30	5.73	9.12

Competitive Comparison of IDL Biotech AB's EV-to-Revenue

For the Diagnostics & Research subindustry, IDL Biotech AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDL Biotech AB's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Biotech AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where IDL Biotech AB's EV-to-Revenue falls into.

IDL Biotech AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

IDL Biotech AB's EV-to-Revenue for today is calculated as:

IDL Biotech AB's current Enterprise Value is kr178.50 Mil.
IDL Biotech AB's Revenue for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was kr19.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDL Biotech AB  (XSAT:IDL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

IDL Biotech AB's PS Ratiofor today is calculated as:

IDL Biotech AB's share price for today is kr2.88.
IDL Biotech AB's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDL Biotech AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

IDL Biotech AB (XSAT:IDL) Business Description